News Announcement

Thyrocare Technologies: Results - Financial Results - Year Ended 31-03-2019

The Board of Directors of the Company at their meeting held today approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended 31-03-2019 and have recommended a dividend of Rs. 20.00 (Rupees Twenty only) per share (200% of the face value of Rs. 10/- each). The Meeting concluded at 9.15 p.m. today.

Besides the Board also approved granting of Stock Options to the eligible employees of the Company for the year 2018-19 subject to approval by Members.

Pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulations 2015 the following are attached.

1. Stand-alone and Consolidated Audited Financial Results for the quarter and the financial year ended 31-03-2019.
2. Auditors Report on the Stand-alone Financial Results for the year ended 31-03-2019.
3. Auditors Report on the Consolidated Financial Results for the year ended 31-03-2019.

The statutory auditors have issued unmodified opinion on both e Stand-alone and Consolidated Financial Results.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.